Cyteir Therapeutics, Inc.
CYTDelisted Mar 18, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001662244
Cyteir Therapeutics, Inc. was delisted on Mar 18, 2024; its insiders filed their last Form 4 on Mar 25, 2024; 38 institutions reported holding it in 13F filings for Q4 2023, worth $38.9M in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Cyteir Therapeutics, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 45 | 37 | −8 |
| Shares | 19.0M | 18.0M | −1.03M (−5.4%) |
| Value | $56.8M | $34.6M | −$22.2M (−39.1%) |
New holders (2)
Institutions that held Cyteir Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Mariner, LLC | 11,852 | $23.0K | 0.00% |
| China Universal Asset Management Co., Ltd. | 332 | $1.00K | 0.00% |
Sold out (10)
Institutions that held Cyteir Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| D. E. Shaw & Co., Inc. | 58,529 | $175.0K |
| Two Sigma Securities, LLC | 17,557 | $52.0K |
| Bailard, Inc. | 13,900 | $42.0K |
| Cubist Systematic Strategies, LLC | 11,282 | $34.0K |
| Ergoteles LLC | 10,278 | $31.0K |
| New York State Common Retirement Fund | 189 | $1.00K |
| Barclays PLC | 100 | $0 |
| Meeder Asset Management Inc | 3 | $0 |
| Credit Suisse AG | 10 | $0 |
| Ellevest, Inc. | 49 | $0 |